Clinical trial

Fuzzy Logic Automated Insulin Regulation

NCT03040414

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-06-03

PhaseNA

Study timeline

Study start (actual)2019-06-03Date precision: day

Registry last updated2021-04-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 1 Diabetes Mellitusunresolved

Interventions

MedtronicMinimed 670G 3.0 hybrid closed loop systemDEVICE

Medtronic Minimed 670G 4.0 AHCL with Guardian Sensor (3) continuous glucose monitoring sensor.DEVICE

Sponsors & collaborators

HealthPartners Institutelead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

Medtroniccollaborator

Jaeb Center for Health Researchcollaborator

Schneider Children's Medical Center, Israelcollaborator

University of Ljubljanacollaborator

Yale Universitycollaborator

Joslin Diabetes Centercollaborator

University of Floridacollaborator

Stanford Universitycollaborator

International Diabetes Center at Park Nicolletcollaborator

Kinderkrankenhaus auf der Bultcollaborator

University of Minnesotacollaborator

Mapped research locations

BostonMassachusetts, United States1 New HavenConnecticut, United States1 GainesvilleFlorida, United States1 HanoverGermany1 Petah TikvaIsrael1 Saint Louis ParkMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03040414 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.